Pancreatic Cancer Research

ResearcherFlorida Hospital Cancer InstituteNo recent work listed

Sally A. Litherland

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0976-1901; OpenAlex author ID A5081876348. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal… Last author DOI 10.1371/journal.pone.0265725↗
  2. Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation. Last author DOI 10.1097/mpa.0000000000000667↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. J. Pablo Arnoletti · 2 shared papers, 2017–2022 · strength 0.20
  2. Otto Phanstiel · 1 shared paper, 2022 · strength 0.14
  3. Deborah A. Altomare · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.